This hypothesis was supported by the observed elevated expression of GSDMD in individuals with SLE and further corroborated by the beneficial effects of GSDMD inhibitors in alleviating symptoms in lupus‐prone mice.15 Here, GSDMD is linked to systemic lupus erythematosus.